Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AP-cannabinoids
- Development stage
- Unknown
- Lead developer
- Decoy Biosystems
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
AP-Cannabinoids is a gastro-retentive, controlled-release oral formulation of cannabinoids developed by Intec Pharma using its proprietary Accordion Pill (AP) technology. The platform consists of a multi-layered, biodegradable film containing the active pharmaceutical ingredients—typically cannabidiol (CBD) and tetrahydrocannabinol (THC)—which is folded into a standard-size capsule. Upon reaching the stomach, the pill unfolds and is retained in the gastric cavity for several hours, allowing for continuous release and improved bioavailability of the cannabinoids, which otherwise have poor and erratic absorption profiles. The program was primarily targeted at treating chronic pain conditions such as low back pain and fibromyalgia.
- Other names
- Accordion Pill Cannabinoids
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on AP-cannabinoids.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AP-cannabinoids.